M&T Bank’s iShares US Pharmaceuticals ETF IHE Stock Holding History

M&T Bank’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,164	Closed	-$224K	–	1761
2015 Q4	$224K	Sell	4,164 -261	-6%	-$13.7K	﹤0.01%	1450
2015 Q3	$218K	Buy	4,425 +237	+6%	+$13.6K	﹤0.01%	1484
2015 Q2	$244K	Sell	4,188 -2,040	-33%	-$119K	﹤0.01%	1629
2015 Q1	$358K	Buy	+6,228	New	+$341K	﹤0.01%	1346

Other funds holding IHE

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

SFI

SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return

Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

EAMA

EFG Asset Management (Americas) Miami, Florida $579M AUM 24.22% 1-Year Est. Return

M&T Bank's IHE Position: Q1 2016 in Review

M&T Bank sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2016, closing a stake of 4,164 shares — an estimated $224K sold.

M&T Bank first reported a position in IHE in Q1 2015 and held it in 4 quarters. The position peaked at $358K in Q1 2015. 91 funds tracked by Wall St. Rank hold IHE as of Q1 2016.

M&T Bank reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2016 after selling out during the quarter.
M&T Bank sold 4,164 iShares US Pharmaceuticals ETF shares in Q1 2016, an estimated $224K.
M&T Bank first reported a position in iShares US Pharmaceuticals ETF in Q1 2015 and held it in 4 quarters.
M&T Bank's iShares US Pharmaceuticals ETF position peaked at $358K in Q1 2015.
91 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2016.

Based on M&T Bank's 13F filing for Q1 2016, filed 11 May 2016.